Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Sørbye LM, Nilsen RM, Klungsøyr K, Morken NH, Kvalvik LG, Nohr EA, Skjaerven R, Catov J(2026) Gestational Diabetes Mellitus in Second Pregnancy by Adverse Outcomes of First Pregnancy: a Population-based Historical Cohort Study Am J Epidemiol(in press) DOI 10.1093/aje/kwag213, PubMed 42706880
Nymoen HM, Zhao Z, Horndalsveen H, Bjaanæs MM, Grønberg BH, Halvorsen T, Madebo T, Aanerud M, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Ahvonen J, Silvoniemi M, Alver TN, Dalen T, Öjlert ÅK, Farooqi SJ, Helland Å, Haakensen VD(2026) Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy Mol Oncol(in press) DOI 10.1002/1878-0261.70326, PubMed 42703809
Sollid LM(2026) One mechanism, two diseases: Involvement of enzyme-substrate complexes in the pathogenesis of celiac disease and rheumatoid arthritis Proc Natl Acad Sci U S A, 123(37), e2600933123 DOI 10.1073/pnas.2600933123, PubMed 42696555